Michael Jantz is a Respiratory physician affiliated with University of Central Florida. OpenAlex indexes 589 publications with 5,185 citations (h-index 31); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-392-2666Registry record last updated 1 Feb 2022.
Clinical trials
- Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction
Sponsor: University of Florida
- Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GE HEALTHCAREProgram year20258 payments$22,619openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year202515 payments
- Pulmonx CorporationProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
50.3%Corticosteroid39.2%Breztri Aerosphere63%Trelegy Ellipta26%Symbicort8%Breo Ellipta4%Part D<11 patientsbeta2-Adrenergic Agonist8.3%Albuterol Sulfate Hfa100%Part D≥23 patients+ 1 more class in this area
Metabolism & gastrointestinal
21.3%Corticosteroid13.2%Prednisone100%Part D≥27 patientsProton pump inhibitor8%Pantoprazole Sodium77%Rabeprazole Sodium23%Part D<11 patientsAnti-infectives
14.3%Macrolide Antimicrobial4.5%Azithromycin100%Part D<11 patientsAntimycobacterial3.2%Ethambutol Hcl100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Vitamin C, Thiamine, and Hydrocortisone in the Treatment of Sepsis: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
Journal of Intensive Care Medicine
2021 - Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial
Annals of the American Thoracic Society
2020 - Diagnostic Accuracy of Endobronchial Ultrasound Transbronchial Needle Aspiration in Lymphoma. A Systematic Review and Meta-Analysis
Annals of the American Thoracic Society
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Tolentino, MD
University of Central Florida
William Decampli, MD
University of Central Florida
Sergio Larach, MD
University of Central Florida
Naren Ramakrishna, MD, PhD
University of Central Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”